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Summary
We have studied the mouse lysozyme (ML) peptide-specific T cell repertoirein mice offive different
major histocompatibility complex (MHC) class II haplotypes. 14 ML peptides were tested in
a lymph node T cell proliferation assay. Upon immunization ofdiverse mouse strains with native
ML, there was no response to any of the ML peptides tested. However, nine peptides were
immunogenic, although there was no consistent pattern of reactivitytoward any peptide among
these strains. Thus, an autoreactive-T cell repertoire directed against cryptic self(ML)-determinants
exists, and it is different in mice of different MHC haplotypes. Moreover, our results demonstrate
that crypticity is MHC associated and not merely a structural attribute of the determinant. On
comparison ofthe pattern ofresponse ofvarious peptides ofML and that of its foreign homologue,
hen eggwhite lysozyme (HEL) in H-2k, H-2b, and H-2d strains of mice, a striking correlation
was evident. The stretches of amino acid sequences of determinantswithin HEL that were dominant
in each of these three strains, almost exactly overlapped in position with those of the cryptic
ML determinants against which self-reactivity was demonstrated in the same strain. These results
demonstrate that the dominance-crypticity relationship between HEL and ML resulting from
differential processing ofthese two proteins is critical in determining the response to HEL rather
than thedegree ofsequence differencebetween them. Theseobservations have important implications
in the shaping of the T cell repertoirefor foreign proteins and in the pathogenesis ofautoimmunity.
T
he repertoire of mature cilO T cells found in the blood
and peripherallymphoid organs is selectedby MHC prod-
ucts and self-antigens expressed in the thymus. Immature
thymocytes that express TCR with a threshold affinity for
self-MHC-self-peptide complexes preferentially emigrate from
the thymus into the periphery (positive selection), whereas
autoreactive thymocytes that recognize self-antigen-MHC
complexes with a high affinity are deleted (negative selec-
tion). Self-tolerance is established in part through negative
selection, and in part through peripheral mechanisms such
as anergy induction, downregulation of TCR, or suppres-
sion (1-10).
Lorenz and Allen(11) provided functional evidence in mice
that APC from several tissues can process and present the
self-antigen, hemoglobin (Hb). 1 They demonstrated that
t Abbreviations used in this paper. t-Boc, tent-butyloxycubosryl; DIC, N,N'-
diisopropylcarbodiimide; DIEA, NN-diisopropylethylamine; DCM, dichlo-
romethane; Hb, hemoglobin; HEL, hen eggwhite lysozyme; hsp, heat-
shock protein; ML, mouse lysozyme.
these APC could stimulate self-Hb-specific hybridomas
without addition of exogenous antigen, indicating that de-
terminants within self-Hb are expressed on the surface ofthe
APC. Stockinger and Lin (12) have described that intracel-
lular pro-C5 (the precursor of the fifth component of com-
plement) was processed and presented by macrophages from
C5-deficient mice, and could activate class II-restricted C5-
specific T cell clones. We have previously reported that two
self-class II peptides (A. 1-18 and Ak kp 1-16) and one self-
class I peptide (Ld 61-85) were immunogenic in B10.A mice,
but another self-class I peptide P 61-85) was nonimmuno-
genic although it could bind with high affinity to the Ak
molecule and presumably induced tolerance during develop-
ment (13) . Similar results have also been reported usingpep-
tides containing sequences from the ci and S chains of the
I-Ad molecule (14) . Thus, there are two functional sets of
self-determinants, those that are easily processed and presented,
readily tolerizing developing T cells and comprisingthe dom-
inant self, and those that are difficult to present and do not
tolerize, comprising the cryptic self.
At present, it is believed that if a determinant within a
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on the homologous self-protein, then its chances of being
immunogenic are high. However, we suggest that the rela-
tionship between crypticity and dominance in the host an-
tigen vis-a-visits homologue, rather than the degree of se-
quence difference/foreignness between the two proteins, is
the major factor in determining the immune response to a
foreign protein. Immunogenicity of related foreign deter-
minants can be entirely dependent on the level of crypticity
of the determinants in the self-homologue. High crypticity
will ensure that Tcellsdirected against the self-determinants
are not purged from the repertoire. Moreover, as a result of
differential processing of the selfand foreign proteins owing
to differences in amino acid sequences flanking each of the
potential epitopes, determinants that have an identical posi-
tion in the two proteins might nevertheless show a different
pattern (dominant or cryptic) of immunogenicity.
We have now examined this issue using mouse lysozyme
(ML) as amodel self-protein andtheresults described in this
studysupport the aforementioned hypothesis. Different cryptic
determinants within ML were found in mice of five different
MHC haplotypes, each strain revealing a unique pattern of
crypticity. Moreover, the determinants on hen eggwhite lyso-
zyme (HEL), a foreign homologue of ML, that correspond
in position to thecryptic ML determinants were dominant .
Theseresults suggest that crypticity of self(ML)-determinants
playsa critical role in influencing theimmunogenicity of de-
terminants on HEL.
Materials and Methods
Mica
￿
BALB/c (H-2d), B10.D2 (H-2d), CBA/J (H-2k), B10.PL
(H-2°), BALB.B (H-26), C57BL/6 (=B6) (H-26), and SJL (H-2')
mice were purchased from TheJackson Laboratory (Bar Harbor,
ME) and bred in our animal facility.
Peptide Synthesis andPurification.
￿
ML peptides were synthesized
by threedifferentmethods: (a)ML peptides (mostly 15-mers) were
synthesized in our laboratory using the rapid simultaneous solid-
phase multiple-peptide synthesis methodology, the so-called
"teabag" method,whichis basedon Merrifield's original solidphase
procedure (15). Peptides were generated on tert-butyloxycarbonyl
(t-Boc) amino acid-Pam resins contained within porous polypro-
pylene bags. Theseresins andt-Bocaminoacid residues having the
appropriate side chain protecting groups were obtained from Ad-
vanced ChemTech, Louisville, KY,andPeninsula Laboratories, Inc.,
Belmont, CA. Atypicalcycle ofreactionsincluded deblocking (or
deprotection), neutralization, coupling, and washing. The coup-
ling steps were done individually but other steps were done with
allteabags in acommon solution. Deblocking wasdonewith 55%
TFA in dichloromethane (DCM) containing 2-methylindole
(0.05%, finalconcentration). Followingdeblocking, theresins were
washed sequentially in DCM, 2-propanol, DCM, 5% N,N-diiso-
propylethylamine (DIEA) in DCM, andDCM. During theinterim
period, the appropriate t-Boc amino acid residues were activated
either with N,N'-diisopropylcarbodiimide (DIC)/DCM (for DIC
esters) or with DIC/N,N-dimethyl formamide (DMF) (for 1-hy-
droxybenzotriazole esters) . Upon completion of postdeblocking
washes, theactivatedamino acidswere added to theresins to allow
coupling of the next amino acid in the sequence. The coupling
reaction was allowed to proceedfor at least 6h or overnight. After
2132
the coupling reaction was over, the resins were washed sequen-
tially in DCM, DMF, andDCM.Thereafter, theefficiency ofcoup-
ling was tested on a small sample of the resin by the ninhydrin
test. If needed, the resin was subjected to recoupling. After the
last coupling of each peptide, a final deblocking was done. The
reagents and solvents used in the above-mentioned cycle of reac-
tionswere obtained from Aldrich Chemical Company, Milwaukee,
WI; Fisher Scientific, Fair Lawn, NJ; and Sigma Chemical Com-
pany, St. Louis, MO.
After thefinaldeblocking, peptides were cleaved from theresin
using the low trifluoromethane sulphonic acid cleavage method
(Applied Biosystems, Inc., Foster City, CA). The peptides were
then desalted by passing over a Sephadex G10 column (Pharmacia
Fine Chemicals, Piscataway, NJ) using30% acetic acid. The pep-
tide fraction was analyzed by HPLC (Gilson Medical Electronics,
Inc., SanDiego, CA)usinga Hi-Pore C-18 column (Bio-Rad Labora-
tories, Richmond, CA), and was further purified as a single peak
on a preparative column (G4; Brownlee Labs., Santa Clara, CA)
with a solvent system of 0.1% TFA and an increasing gradient of
acetonitrile. Allpurified peptides were subjected to amino acid com-
position analysis. For this purpose, the peptide sample was hydro-
lyzed in 6 N HCl at 110°C for 18 h under vacuum in a nitrogen
atmosphere, andthe Waters PicoTagmethod (Millipore, Milford,
MA)was used fordetermining the amino acid composition of the
peptides (16). (b) A complete series of overlapping peptides span-
ning the entire sequence of ML were synthesized by Dr. H. M.
Geysen (Chiron Mimotopes, Clayton, Australia) usingthe "multi-
pin" peptide synthesis technique. The procedure had been modified
as describedin detail elsewhereso that thepeptides couldbe cleaved
from thepins (17). Thefirst aminoacid residue addedin each case
was proline followed by Boc-lysine(Fmoc)-OH. The Fmoc pro-
tecting group was then removed, and additional Fmoc-protected
amino acids were added onto the e-amino group of the lysine by
repetitive cycles of Fmoc deprotection and amino acid couplings.
The terminal amino group of each peptide was acetylated. After
removal of all the protecting groups, cleavage from the pins was
performedby exposure to neutral pH, under whichconditions the
COOH-terminal lysine-prolneresidues formed diketopiperazine.
Peptide yield was estimated as described (17). (c) Some of the ML
peptides were synthesized byDr. CraigMiles, Macromolecular Re-
sources, Colorado State University, Fort Collins, CO. Manual
or automatedpeptidesynthesis was performed using t-Bocamino
acids. The aminoacid residues were activated with 0.9 equivalents
of 2-(1H-benzotriazol-1-yl)1,1,3,3-tetramethyluronium hexafluoro-
phosphate and 1.4 equivalents of DIEA. The peptide resin com-
plex wasdeprotected with 50% TFA, washed,andneutralized with
DIEA. The activated amino acids were stirred into the peptide-
resin complex and reacted for 30 min. The coupling efficiencies
were determined by theninhydrin assay. Thepeptides were removed
from the synthesis resin in 90% hydrogen fluoride with 10%
ethanedithiol as acation scavenger. Thecrudeproducts were purified
using HPLC.
Preparation ofMouse Lysozyme(ML).
￿
ML is secreted byJ774A.1
cells (AmericanType CultureCollection, Rockville, MD), amouse-
monocyte-macrophage cell line that synthesizes ML. This cell line
wasmaintained in DMEM (Gibco Laboratories, GrandIsland, NY)
containing 10% heat-inactivated FCS (Gemini Bioproducts, Inc.,
Calabasas, CA), 5 x 10 -s M 2-ME (Sigma Chemical Co.), 2 mM
c-glutamine, 100U/ml penicillin, and 100,ug/mlstreptomycin (all
from GibcoLaboratories, Inc.). Then it was grown as a tumor in
the peritoneal cavity of BALB/c mice, which were injected in-
traperitoneally with 0.5 ml of 2,6,10,14-tetramethyl pentadecane
(Pristane; AldrichChemical Co., Inc.) 1 wk before injecting 1-2 x
Relationship of Crypticity/Dominance in Self-protein and Foreign Homologue10 7J774A.1 cells. After 2-3 wk, the ascitic fluid was tapped from
the peritoneal cavity, centrifuged at 1,500 rpm for 10 min, dia-
lyzed against PBS, and then used as a source ofML . The activity
ofML was tested using the Micrococcus lysodeikticus lysis assay (18) .
The concentration of ML in the ascitic fluid was as high as 300
kg/ml.
Lymph Node Proliferation Assay.
￿
Groups of at least four to six
mice (8-16wk old) were immunizedwith 7or 14 nmol permouse
of a ML peptide or with 14 or 21 nmol per mouse of native ML
in saline or PBS, in a 1:1 (vol/vol) emulsion with CFAcontaining
1 mg/ml Mycobacterium tuberculosis strainH37Ra (Difco Laborato-
ries, Detroit, MI), in the hind footpads . After 9 d, the popliteal
lymph nodes were removedand cell suspensions prepared . Thede-
bris was allowed to settle, and the cells in the supernatant were
washed twice with HBSS (Gibco Laboratories Inc.). The lymph
node cells were cultured in 96-well plates at 5 x 105 cells/well,
in duplicate or triplicate samples, in Hlrl serum-free medium (Ven-
trex Laboratories, Inc., Portland, ME) supplemented with 2mM
L-glutamine, 100 U/ml penicillin, and 100 ug/ml streptomycin,
and different concentrations (1.75-14 P.M, final concentration) of
the antigen. For the pin peptides, one or two wells were tested
per peptide. Tuberculin purified protein derivative (Evans Medical
Limited, Horsham, England) was used at a final concentration of
2,000 U/well as a positive control . 1 uCi of [3Hlthymidine (In-
ternational Chemical and Nuclear, Irvine, CA) wasadded per well
for the last 18 h of a 5-d culture . Then, the cells were harvested
on Printed FiltermatA glass fiber filter (Wallac, Turku, Finland)
using a Micro Cell Harvester (Skatron Instruments, Inc., Sterling,
VA) and the incorporation of radioactivity was assayed by liquid
scintillation counting, using a Betaplate counter (1205 ; LKB In-
struments, Inc., Gaithersburg, MD). The resultsfrom a single an-
imal were recorded as meancpmof duplicate or triplicate cultures,
with background (medium alone) values subtracted. The final results
from a group of animals immunized with the same peptide were
expressed as mean cpm ± SD. The results obtained withML pep-
tides synthesized by the "teabag" method were confirmed with
pin peptides as well as with peptides obtained from Macromolecular
Resources, and vice versa .
1-15
￿
KVY ERCE FARTLKRN
￿
ML
--FG---L-AAN--H NEL Figure 1 . Amino acid se-
quences of 14 ML peptides used
in this study. For eachpeptide, the
19-33
￿
6YYGVSLA0WVC LAQ
N - R - Y - - 6N - - - A - K
￿
sequence ofML peptide is given
on the top, and that for the cor-
responding HEL peptide immedi-
ately below. Only those amino
acid residues oftheHEL peptide
that differ from the amino acidres
37-50
￿
N YNT R A T NYN R G D Q 5
￿
ldue ofML at the particular pose- - F - - Q - - - R - T " - G - on are depicted The singleletter n .-
amino acid code is used . The
asterisk at position 48 inHEL cor-
responds to an extra amino acid
(G) in ML at that position. For
accuratecomparison ofthe bound-
95-109
￿
AKRVVR0 PQG I RANV
- - K I - S - 6N - N N - - -
￿
aries and sequences ofpeptides of
ML andHEL, wehave numbered
G48 in ML as "G47a" The lyso-
zyme sequences were obtained
from theNational Biomedical Re-
search Foundation data base.
10-23
￿
RT LKRNGMAGYYGV
AAM - - H - L DN - R - Y
22-36 6VSLADNVCLAQHEs
-Y--GN---A-KF--
31-45
￿
LAQH ESNYNTRATNY
A-KF---F--Q---R
34-47a HESNYNT4ATNYNRG
F---F--Q---R-T .
40-53
￿
TRATNYN RGDQST0Y
66-79
￿
DGKT PRAVNACG I N
- - R - - 6 5 R - L - N - P
77-91
￿
G I NC SA L LQD01 TAA
N-P-----55----5
99-113
￿
VRDPQ61 RANVANRA
.S-GN-MN------N
105-119
￿
1 RANVANRAHCQNRD
MN------NR-K6T-
116-129
￿
QNRDL SQY I RNC6V
K 6 T - V QAN - - 6 - R L
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Results and Discussion
Mice ofDifferentMHC Haplotypes Have Unique Patterns of
Response to Cryptic ML Determinants. 14ML peptides (Fig.
1) were tested in lymph node proliferation assay in mice of
three different MHC haplotypes : BALB/c -(H-2d), CBA/J
(H-2k), and C57BL/6 (H-2b) . From this set of partially
overlapping ML peptides, whoseboundaries were sometimes
chosen to avoid difficult synthetic situations, five were nonim-
munogenic in each of the three strains . Of the remaining
nine peptides, BALB/c mice gave a positive response to only
one peptide, whereas CBA/J and C57BL/6 mice responded
to sevenand three peptides, respectively (Fig. 2) . The results
obtained with ML peptides synthesized by the "teabag"
method were confirmed with pin peptides as well as with
Figure 2 .
￿
The in vitro T cell proliferative response ofLN cells to ML
peptides in mice of differentMHC haplotypes . Mice were immunized in
the hind footpads with one of the ML peptides emulsified in CFA, and
after 9 d, the response of the LN cells was recalled in vitro with the same
peptide. A, B, andC correspond to CBA/J (H-2k), BALB/c (H-2a), and
C57BL/6 (H-2b) mice, respectively. The peptide number shown corre-
sponds to the amino acid residues ofML as follows: 1, 1-15 ; 2, 10-23 ;
3, 19-33 ; 4, 22-36; 5, 31-45 ; 6, 34-47a ; 7, 37-50 ; 8, 40-53 ; 9, 66-79 ;
10, 77-91; 11, 95-109 ; 12, 99-113 ; 13, 105-119; and 14, 116-129 . The
response ofML peptides (meancpm ± SD)shownrepresents results from
four to six animals ofeach strain . The response to purified protein deriva-
tive for each peptide is not shown, but it ranged from 22,769 to >200,000
cpm in different experiments .peptides obtained from Macromolecular Resources, and vice
versa (data not shown). Thus, each of the three strains of
mice tested had ML-peptide reactive T cells in their reper-
toire. Importantly, each strain revealed a unique pattern of
response to the panel of ML peptides. These results are shown
in tabular form in Table 1, along with partial results from
two other independent MHC haplotypes, H-2° (B10.PL)
and H-2s (SJL). Again, the pattern of reactivity to ML pep-
tides appears unique to each haplotype. The data in Table
1 demonstrate that : (a) BALB/c mice respond to only one
ML peptide, peptide 105-119 (p105-119), whereas SJL (and
also CBA/J, B10.PL, or C57BL/6) mice do not respond to
that peptide. However, SJL mice do give a consistent weak
response to two other ML peptides (p66-79 and p77-91);
(b) CBA/J but not C57BL/6 mice respond to peptides 1-15,
37-50, 40-53, and 116-129, whereas C57BL/6 but not CBA/J
mice respond to peptide 34-47a. However, both CBA/J and
C57BL/6 mice respond to peptides 19-33 and 66-79, although
the degree of response to peptide 66-79 is quite different in
the two strains; (c) both B10YL and CBA/J mice respond
to peptide 116-129, whereas BALB/c, C57BL/6, or SJL mice
fail to give a response to this peptide; however, CBA/J and
B10YL mice differ in their response to peptide 19-33; (d)
although both CBA/J and SJL mice give a consistent weak
response to peptides 66-79 and 77-91, only CBA/J mice re-
spond to peptide 116-129. In brief summary, collective re-
sponses to ML were scattered throughout the molecule with
each strain showing a reproducible and limited pattern of T
cell proliferative response.
Upon immunization ofmice with the native ML emulsified
in CFA, there was no recall response to any of the ML pep-
tides tested (data not shown). Since nine of these ML pep-
tides were immunogenic when injected in the peptide form
(Table 1), these results suggest that the determinants corre-
sponding to the immunogenic ML peptides are either not
generated from the processing of the whole ML molecule,
or they are generated but not efficiently presented to T cells
to induce a response. In this context, the immunogenic ML
peptides represent "cryptic" self-determinants. ML is a self-
protein that is present in the blood, and the protein as well
as its messenger RNA have been shown to be also present
in the thymus and other tissues (19, 20). During develop-
ment ofthe T cell repertoire, dominant determinants within
ML should lead to deletion or anergy of the ML-reactive T
cells. On the contrary, T cells potentially reactive to cryptic
ML determinants would evade tolerance induction, permit-
ting these T cells to be recruited in adulthood by specific
peptides to induce a response (21-23). Thus, we provide evi-
dence that self-reactivity exists to several cryptic ML deter-
minants in mice, and that the ML-specific autoreactive T cell
repertoire is different in mice of different MHC'haplotypes.
CrypticityIs MHCAssociated.
￿
To determine theinfluence
of MHC and non-MHC (background) genes on the pattern
ofcrypticity of determinants within ML, the response of six
ML peptides was tested in mice ofthree different MHC haplo-
types, including MHC-congenic strains, using the lymph node
proliferation assay. The results are given in Table 2. It was
found that the pattern of response of different ML peptides
in C57BL/6 (H-2b) mice was completely different from
that in B10.D2 (H-2d) or B10.PL (H-2°) mice of disparate
MHC, whose background is almost identical to that of
C57BL/6 mice. On the contrary, the pattern of response of
C57BL/6 mice to the same peptides correlated precisely to
that of BALRB (H-2b) mice, which have the same MHC
as C57BL/6 mice but a different non-MHC background. Simi-
larly, the pattern of response of BALB/c (H-2d) mice was
identical to that of B10.D2 (H-2d) mice of the same MHC
haplotype, but with different non-MHC genes. On the con-
trary, there was no similarity, whatsoever, in the patterns of
response of BALB/c (H-2d) and BALRB (H-2b) mice, which
have the same background but are of different MHC haplo-
type. These observations clearly demonstrate that a cryptic
determinant in one haplotype is not necessarily cryptic in
another: crypticityis MHC associatedand not merely a struc-
tural attribute of the determinant.
The strong association between the crypticity of a deter-
minant and the MHC of the host couldbe attributed to the
ability of a potentially cryptic determinant to bind to MHC
class II molecules of a particular haplotype, as well as to the
predominant influence of MHC genes on the development
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Mice of different MHC haplotypes were immunized in the hind footpads with one of the ML peptides emulsified in CFA. After 9 d, lymph node
cells were tested for a proliferative response to the same peptide in vitro. The results of the assay were recorded as a stimulation index (S.I.) =
cpmwith antigen/cpm without antigen. Theresponse to each peptide was determined in four to sixindividual mice. Based on thevalue of average
S.I., theresponse to each peptide was arbitrarily graded as follows: S.I. of <3, -; 3-3.9, ±;4-9.9, + ; 10-24.9, 2+ ; 25-49.9, 3+ ; and50-100, 4+ .
Table 1.
Strain
The
1-15
Pattern of
10-23
Response
19-33
of ML
22-36
Peptides
31-45
in Mice
34-47a
ofDfferent
ML
37-50
MHC
Peptide
40-53
Haplotypes
Tested
66-79 77-91 95-109 99-113 105-119 116-129
BALB/c - - - - - -
CBA/J 3+ - 3+ - - - + 4+
C57BL/6 - - 3+ - - 2 + - 3+ - - - - -
SJL ND - ND ND ND ND ND ND
B10.PL ND - - - ND ND ND ND 3+Table 2.
￿
Profiles of Responses to ML Peptides in MHC-congenic
Strains of Mice
Mice of threedifferentMHChaplotypes, includingMHCcongenic strains,
were immunizedin thehind foot pads with oneof the ML peptides emul-
sified in CFA, andafter9d, thelymph node cell proliferation assaywas
performed. The response to each peptide, determined in four individual
mice, was graded as described in Table 1. The figures in parentheses
represent average stimulation indices .
of the T cell repertoire. In a recent study (Grewal, I. S., and
E. E. Sercarz, manuscript in preparation), it was found that
non-MHC genes had a limited effect on the expression of
the T cell repertoire. In mice of six different non-MHC back-
grounds but identical MHC (Ab), there was only one anti-
HEL repertoire difference among all these strains. However,
in another study (Grewal, I. S., K. D. Moudgil, and E. E.
Sercarz, manuscript submitted for publication), we have ob-
served that a determinant within HEL that induces a strong
T cell response in one strain of mice can be nonimmuno-
genic in another strain of mice of identical MHC but of
different background. The nonresponder strain was found
to be defective in its ability to "fine-process" that determinant,
which was critical for its immunogenicity. Therefore, the
influence of non-MHC genes on crypticity of a determinant
cannot be completely ruled out.
Comparison of the Patterns of the T Cell Response ofH-2k,
H-26, andH-211 Strains ofMice to ML andHEL. In view of
the above observations, it was pertinent to ask if there was
any relationship between self-reactivity to ML peptides and
the T cell response to determinants on the homologous for-
eign antigen, HEL. The T cell response to HEL has been
extensively studied in our laboratory (21, 24-27) and by others
(28, 29). Upon immunization with HEL (emulsified in CFA)
in the footpad, CBA/J (or B10.A/C3H), C57BL/6, and
BALB/c mice reveal characteristic profiles of lymph node T
cell proliferative responses when tested with various HEL pep-
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Table 3. Relationship between
ML and Dominant Determinants
MHC Haplotypes
the Cryptic Determinants within
on HEL in Mice of Diferent
" Codominant in C3H and CBA/J, but cryptic in B10.A mice.
t HEL peptide 20-35 also gives an equally good response.
S 74-86 is a subdominant determinant in mice ofH-2k haplotype. At this
time, we do not know the minimal determinant that is recognized by
H-2k or H-2b strains in ML 66-79. Therefore, the corresponding HEL
determinant is repeated for 74-86 (H-2k) as well as 74-90 (H-2b).
The peptides listed under ML are theones that are immunogenic, cryp-
ticpeptides in mice of that particular MHC haplotype. Thepeptides depict-
ed underHEL represent dominant determinants within HEL, to which
mice of that MHC haplotype respond after immunization with native
HEL. Statistical analysis of the data was done by computing thep value,
to evaluate thestatistical significance ofthe observed concordance of strain-
specific cryptic and dominant determinants. Thep value was found to
be 0.082 for H-2k mice, 0.022 for H-2b mice, and 0.049 forH-211 mice.
All these three values of p were highly significant.
tides(Table 3). Also listed in Table 3 are the cryptic ML pep-
tides that were found to be immunogenic in mice of three
different MHC haplotypes.
In each ofthe three strains ofmice ofdifferent MHC haplo-
types tested, there is a remarkable correlation between the
lymph node T cell proliferative responses to ML peptides and
HEL. In particular, the positions of the determinants within
ML that are cryptic in H-2k mice match almost precisely the
dominant determinants on HEL that induce a response in
that strain when the native molecule is used as immunogen.
Surprisingly, some of these ML peptides differ from the cor-
responding HEL peptides by as many as 7-10 amino acids
(Fig. 1). A similar correlation is observed in mice of the
H-2b and H-211 haplotypes. The only "mismatches" are in
the area from 66-86. These results demonstrate that ML and
HEL are processed differentially: regions dominant in HEL
and presumably readily processed, are cryptic on ML, but
immunogenic when presented as ML peptides. It has been
shown that even a single amino acid substitution can alter
T cell determinant selection during antigen processing (30).
Accordingly, differences in the processing of ML and HEL
can be attributed to the vast differences between the amino
acid sequences of these two related proteins (55 amino acid
residues/130 amino acids). Thus, sufficient variation is provided
ML
peptide
B6
(H-2b)
BALB.B
(11-26)
BALB/c
(11-211)
MOM
(H-211)
B10.PL
(11-2°)
19-33 3+ 3 + - - -
(48.7) (30.8) (1.4) (1) (1.6)
22-36
(1) (1.6) (2.3) (1 .5) (1.6)
66-79 3+ 2+ - - -
(43.7) (16.4) (1.4) (1 .3) (2.1)
95-109
(1) (1 .6) (1) (1 .6) (2)
105-119 - - 3+ 3+ -
(1) (1 .9) (32.9) (44.9) (2.1)
- - - - 3+
116-129 (2.1) (1 .7) (1) (1 .2) (48.8)
H-2k
ML HEL
H-2b
ML HEL
H-211
ML HEL
1-15 1-17'`
19-33 18-33t 19-33 20-35
37-50 34-45 34-47a 30-53
40-53 ND
ND 46-61 ND ND
66-79 74-865 66-79 74-905
77-91 74-865 - 74-905
105-119 106-116
116-129 116-129Figure 3 .
￿
Priming of T cells by crypticML determinants for response
to HEL . CBA/Jmicewere immunized in a hindfootpad withML peptide
66-79 (A) or with a mixture ofML pin peptides 31-45, 34-47a, 37-50,
and 40-53 (B) emulsified in CFA . After 9 d, the response of the LNC
was recalled with the ML peptide used for immunization or with HEL .
In B, the response was recalled separately with each component of the
mixture of peptides used for immunization . In each panel, the response
of four animals is shown as mean cpm ± SD. Medium, medium control .
The response of mice to PPD was 104,092 (A), and 143,464 (B) .
in the flanking regions ofeach potential determinant to permit
a diversity of new processing sites .
What is the relationship among the antigenic determinants
on protein antigens homologous to a self-protein (a frequent
situation in immunology)? Among the possible determinants
on the related molecule, which ones will be immunogenic
for T cells? The T cell repertoire to a foreign antigen such
as HEL might have been predicted to be related to determinants
that are distinct from self, e.g ., determinants with unique
agretopes or epitopes to which the animal has not been toler-
ized . In fact, there are few very similar regions betweenML
and HEL ; thus, the nearly precise overlap of cryptic ML and
dominantHEL determinants excludes the importance ofdiffer-
ence per se. We noticed in the H-2k 13104 C3H, and
CBA/J strains that there aremany codominant determinants
on HEL that are able to activate the available T cells, while
in the B10.D2 or BALB/c H-2d strains, only one deter-
minant is dominant (21, 24-29). In the case of H-2d BALB/c
mice in particular, one might have predicted a response to
other cryptic determinants on ML or other dominant deter-
minants on HEL than 106-116 . However, no consistent re-
sponse has been seen to otherHEL determinants in this strain
of mouse, even though certain HEL peptides are known to
bind to the Ad (e.g ., 11-25, 20-35, 74-86) or the Ed mole-
cule (e.g., 1-17) (31; Apple, R . J ., H:K . Deng, A . Miller,
E . E . Sercarz, and J . Cogswell, manuscript in preparation) .
Therefore, the lack of response of BALB/c mice to deter-
minants on HEL other than 106-116 is clearly not due to
inability of those determinants to bind to theMHC mole-
cules . Furthermore, based on the above information onMHC
binding, we have excluded the possibility that the identical
patterns of response to determinants within ML and HEL
were due to limited agretypy, i.e., only certain regions in HEL
and the corresponding regions inML had the ability to bind
toMHC molecules in the BALB/c mice . In anycase, the above-
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mentioned possibility would have neither changed the most
important conclusion ofthis study that theML determinants
corresponding to dominant HEL determinants were cryptic,
nor would it have undermined the importance of the cryp-
ticity of certain self(ML)-determinants in allowing potentially
self-reactive T cells to escape tolerance induction .
It may be concluded that differences in the patterns of re-
sponse to HEL in mice of differentMHC haplotypes repre-
sent a conjunction of certain features : (a) the high-affinity
binding of the favored determinants on HEL that are domi-
nant and easily processed, and (b) the existence of a T cell
repertoire that has not been rendered tolerant by the related
ML determinants. It is noteworthy that the repertoire is avail-
able because the homologous determinants on the self-protein
are cryptic. (In fact, this category of determinants may also
include apparently dominant self-determinants that for some
reason have not rendered the potentially self-reactive T cells
tolerant, for example, the Acl-9 determinant on myelin basic
protein may have been inefficiently processed or presented
by the animal's APC.) Accordingly, the unusual relationship
we have described is explicable on the basis of a fortuitous
congruence of crypticity and dominance of determinants
within ML and HEL in each of these strains.
Priming ofHEL Cross-reactive T Cells by Cryptic ML Self-
peptides. A prediction that emerges from this congruence
of position is that cross-reactivity should exist between the
cryptic self-ML peptides and dominant determinants on the
"foreign" congener, HEL, despite the 55-amino acid differ-
ence between the two proteins. In a preliminary set of ex-
periments to explore the above prediction, CBA/J mice were
immunized in a hind footpad withML peptide 66-79 or with
a mixture ofpin peptides (31-45, 34-47a, 37-50, and 40-53
amino acid residues of ML), and the lymph node response
was recalled in vitro with HEL, or with each of the single
peptides employed in the initial immunization . The results
are given in Fig. 3 . These results demonstrate that the cryptic
ML peptides successfully primed T cells, which were then
recruited during the in vitro recall response toHEL. Interest-
ingly, the level of proliferation elicited to HEL was heter-
oclitic and far superior to that induced by the peptide itself.
This may relate to the findings by others showing the im-
portance of B cells in theT cell response to self-antigens (22) .
Possibly, the great disparity between response to the peptide
and HEL favors the idea thatB cell priming to 66-79 or other
ML peptides mentioned above allowed B cells cross-reactive
for HEL to then present other determinants on HEL to am-
bient T cells in vitro. Such activation of naive T cells has
not previously been examined in this system and experiments
to test the validity of this explanation are in progress.
We can postulate that frequently during the lifetime of
the animal, e.g., after subclinical bouts ofinfection, ML will
be produced in excess owing to defensive reactions and up-
regulation of antigen presentation should follow (32). Cer-
tain cryptic ML determinants, those that would be the rela-
tively most easily processed and displayed, will provide a covert
expansion signal to specific T cells. Particular highly cross-
reactive members within this expandedmemoryT cell reper-
Relationship of Crypticity/Dominance in Self-protein and Foreign Homologuetoire would then be selected by relatively dominant deter-
minants on HEL after antigen injection. It may only be a
small subset of the T cells directed against a cryptic self ML
determinant that would be sufficiently cross-reactive with
HEL. We suggest that T cells with the potential to react
with particular cryptic self(ML)-determinants are the ones
that are stimulated by related determinants on the homolo-
gous protein, HEL, although marked differences can be present
in peptide sequence. Recent studies in this laboratory
describing the high level of degeneracy in recognition by in-
dividual T cell receptors (reference 32a; Deng, H.-K., and
E. E. Sercarz, manuscriptin preparation; and Nanda, N. K.,
K. K. Arzoo, H. M. Geysen, A. Sette, and E. E. Sercarz,
manuscript submitted for publication) allow us to extrapo-
late the above results to suggest that the T cell repertoire
to a foreign protein is shaped and focused by the cryptic de-
terminants on the homologous self-protein. Detailed studies
of ML-HEL determinant cross-reactivity and binding of
ML/HEL peptides to MHC molecules to validate this rela-
tionship are underway in the laboratory.
Let us extrapolate to an autoimmune condition, arthritis,
and explore the involvement of cryptic self-determinants. T
cell-mediated responses to a 65-kD heat-shock protein (hsp-
60 family) ofM. tuberculosis have been implicated in the patho-
References
genesis of inflammatory arthritis both in experimental animals
and in humans (33-36). Using synthetic peptides, responses
to shared T cell determinants of the mycobacterial and human
hsp-60 in patients with rheumatoid arthritis have been reported
(35). Based on the ML study reported above, we suggest that
shared cross-reactive determinants on mycobacterial hsp-60
in fact are responsible for induction of rheumatoid arthritis,
but that a particular constellation in the determinant rela-
tionship must exist: the cross-reactive determinants must be
dominant on the bacterial hsp to initiate a host response, while
they have to be cryptic on the self-hsp. The potentially self-
reactive T cells against the cryptic self-determinants are stimu-
lated when the microbial hsp arrives. We predict that explo-
ration of this relationship, which should be true for all cases
of "molecular mimicry" (37), would indicate that autoim-
munity is inevitably associated with the anti-cryptic T cell
repertoire. Furthermore, the immune response to a foreign
homologous protein might be susceptible to tolerization with
the related cryptic self-determinants and vice versa. This would
provide a new therapeutic approach for autoimmune situa-
tions, where external pathogens are implicated in initiating
the autoimmune process. We are currently investigating these
issues.
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